181 related articles for article (PubMed ID: 18424014)
1. Proteasome inhibition as a novel therapy in treating rheumatoid arthritis.
Brun J
Med Hypotheses; 2008; 71(1):65-72. PubMed ID: 18424014
[TBL] [Abstract][Full Text] [Related]
2. Cardiac complications may be higher with use of proteasome inhibitors in patients with rheumatoid arthritis.
Khan S
Med Hypotheses; 2008 Nov; 71(5):818. PubMed ID: 18650027
[No Abstract] [Full Text] [Related]
3. [Proteasome inhibitors: induction of apoptosis as new therapeutic option in prostate cancer].
Tahmatzopoulos A; Gudegast C; Stöckle M; Wullich B; Unteregger G; Zwergel U; Zwergel T
Aktuelle Urol; 2004 Nov; 35(6):491-6. PubMed ID: 15526229
[TBL] [Abstract][Full Text] [Related]
4. Proteasome inhibition for treatment of multiple myeloma: clinical update.
Stadtmauer EA
J Natl Compr Canc Netw; 2004 Nov; 2 Suppl 4():S10-5. PubMed ID: 19795531
[TBL] [Abstract][Full Text] [Related]
5. Moving disease biology from the lab to the clinic.
Anderson KC
Cancer; 2003 Feb; 97(3 Suppl):796-801. PubMed ID: 12548578
[TBL] [Abstract][Full Text] [Related]
6. Wnt signalling in rheumatoid arthritis.
Sen M
Rheumatology (Oxford); 2005 Jun; 44(6):708-13. PubMed ID: 15705634
[TBL] [Abstract][Full Text] [Related]
7. Proteasome inhibition as novel treatment strategy in leukaemia.
Vink J; Cloos J; Kaspers GJ
Br J Haematol; 2006 Aug; 134(3):253-62. PubMed ID: 16787504
[TBL] [Abstract][Full Text] [Related]
8. Synergistic interaction of proteasome and topoisomerase II inhibition in multiple myeloma.
von Metzler I; Heider U; Mieth M; Lamottke B; Kaiser M; Jakob C; Sezer O
Exp Cell Res; 2009 Aug; 315(14):2471-8. PubMed ID: 19410573
[TBL] [Abstract][Full Text] [Related]
9. Proteasome inhibitors in cancer therapy.
Orlowski RZ
Methods Mol Biol; 2005; 301():339-50. PubMed ID: 15917644
[TBL] [Abstract][Full Text] [Related]
10. Proteasome inhibitors in lung cancer.
Scagliotti G
Crit Rev Oncol Hematol; 2006 Jun; 58(3):177-89. PubMed ID: 16427303
[TBL] [Abstract][Full Text] [Related]
11. Proteasome inhibition and multiple myeloma.
Kanagasabaphy P; Morgan GJ; Davies FE
Curr Opin Investig Drugs; 2007 Jun; 8(6):447-51. PubMed ID: 17621873
[TBL] [Abstract][Full Text] [Related]
12. p53 tumor suppressor gene mutations in fibroblast-like synoviocytes from erosion synovium and non-erosion synovium in rheumatoid arthritis.
Yamanishi Y; Boyle DL; Green DR; Keystone EC; Connor A; Zollman S; Firestein GS
Arthritis Res Ther; 2005; 7(1):R12-8. PubMed ID: 15642132
[TBL] [Abstract][Full Text] [Related]
13. Proteasome inhibitors: poisons and remedies.
Meiners S; Ludwig A; Stangl V; Stangl K
Med Res Rev; 2008 Mar; 28(2):309-27. PubMed ID: 17880010
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine kinases as targets in rheumatoid arthritis.
Tristano AG
Int Immunopharmacol; 2009 Jan; 9(1):1-9. PubMed ID: 18848912
[TBL] [Abstract][Full Text] [Related]
15. The proteasome inhibitor bortezomib drastically affects inflammation and bone disease in adjuvant-induced arthritis in rats.
Yannaki E; Papadopoulou A; Athanasiou E; Kaloyannidis P; Paraskeva A; Bougiouklis D; Palladas P; Yiangou M; Anagnostopoulos A
Arthritis Rheum; 2010 Nov; 62(11):3277-88. PubMed ID: 20722034
[TBL] [Abstract][Full Text] [Related]
16. Proteasome inhibitors in pediatric cancer treatment.
Bachmann AS
Hawaii Med J; 2008 Sep; 67(9):247-9. PubMed ID: 18853901
[TBL] [Abstract][Full Text] [Related]
17. Bortezomib-mediated proteasome inhibition as a potential strategy for the treatment of rhabdomyosarcoma.
Bersani F; Taulli R; Accornero P; Morotti A; Miretti S; Crepaldi T; Ponzetto C
Eur J Cancer; 2008 Apr; 44(6):876-84. PubMed ID: 18342500
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II protects fibroblast-like synoviocytes from apoptosis via the AT1-NF-kappaB pathway.
Pattacini L; Casali B; Boiardi L; Pipitone N; Albertazzi L; Salvarani C
Rheumatology (Oxford); 2007 Aug; 46(8):1252-7. PubMed ID: 17526929
[TBL] [Abstract][Full Text] [Related]
19. The therapeutic potential of the proteasome in leukaemia.
McCloskey SM; McMullin MF; Walker B; Irvine AE
Hematol Oncol; 2008 Jun; 26(2):73-81. PubMed ID: 18324639
[TBL] [Abstract][Full Text] [Related]
20. The proteasome: a worthwhile target for the treatment of solid tumours?
Milano A; Iaffaioli RV; Caponigro F
Eur J Cancer; 2007 May; 43(7):1125-33. PubMed ID: 17379504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
